4//SEC Filing
Krasner Alan Seth 4
Accession 0001209191-22-004453
CIK 0001658247other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:54 PM ET
Size
9.6 KB
Accession
0001209191-22-004453
Insider Transaction Report
Form 4
Krasner Alan Seth
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-01-19$12.01/sh+6,700$80,467→ 15,011 total - Sale
Common Stock
2022-01-19$21.21/sh−6,700$142,080→ 8,311 total - Exercise/Conversion
Non-qualified stock option (Right to Buy)
2022-01-19−6,700→ 160,473 totalExercise: $12.01Exp: 2028-06-15→ Common stock (6,700 underlying)
Footnotes (4)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date.
- [F2]Includes 1,928 shares acquired under the Issuer's Employee Stock Purchase Plan since the last Section 16 filing by the Reporting Person.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sales prices range between $20.77 and $21.68. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
- [F4]Stock option granted June 16, 2018 with 25% vesting on the first anniversary of the grant date and the remainder vesting in a series of thirty-six (36) successive equal monthly installments thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001435775
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:54 PM ET
- Size
- 9.6 KB